Stifel analysts reiterated a Buy rating on Edwards Lifesciences Corporation (NYSE:EW) on January 07, 2026.
Edwards Lifesciences Corporation operates in the Healthcare sector. The stock currently trades at $84.77 with a market capitalization of $49,461,263,027.


